Abstract
The clinical treatment of metabolic syndrome, principally that of glucose dysmetabolism (which is characterized by insulin resistance and type 2 diabetes mellitus), is known to be complex and lifelong, which is due to the progressive nature of the disease. Insulin resistance and diabetes mellitus are more commonly associated with obesity. However, the two conditions are not exclusive to t…